| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |